ANL
Adlai Nortye Ltd.
NASDAQ · Healthcare · Biotechnology · KY
$15.01
+1.76%Next report
Analyst consensus
- Next report date
- Mar 3, 2027
- EPS estimate
- -$0.15
- Revenue estimate
- $4.6M
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$0.04
- EPS estimate
- -$0.04
- Revenue actual
- $14.7M
- Revenue estimate
- $12.5M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 3
- Avg surprise (4Q)
- +2.0%
- Revenue beats (12Q)
- 1
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- —
- PT range
- —
- Analysts
- 2
2 Buy0 Hold0 Sell
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 3, 2027